Page last updated: 2024-08-24
fluorexon and bmap-28
fluorexon has been researched along with bmap-28 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bernardi, P; Braidot, E; Gennaro, R; Macrì, F; Risso, A; Skerlavaj, B; Sordano, MC; Vianello, A; Zanetti, M | 1 |
Other Studies
1 other study(ies) available for fluorexon and bmap-28
| Article | Year |
|---|---|
BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Calcium; Cattle; Cell Death; Cells, Cultured; Cyclosporine; Cytochrome c Group; Dose-Response Relationship, Drug; Fluoresceins; Fluorescent Dyes; Humans; Immunity, Innate; Ion Channels; K562 Cells; Leukocytes, Mononuclear; Membrane Potentials; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Proteins; U937 Cells | 2002 |